CLAUDINE DESTINE: Open Payments
NPI 1912454927 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 8 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $246 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, UZEDY, SPRAVATO, Auvelity, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
